Nektar TherapeuticsNASDAQ:NKTR
- LAST PRICE0.6322
- TODAY'S CHANGE (%)-0.0065 (-1.0177%)
- Bid / Lots0.6240/ 20
- Ask / Lots0.6440/ 21
- Open / Previous Close0.6400 / 0.6387
- Day Range
- 52 Week Range
- Volume1,653,740
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NKTR |
|---|---|---|
| 09:32 ET | 4801 | 0.6435 |
| 09:34 ET | 9125 | 0.631 |
| 09:36 ET | 9141 | 0.6318 |
| 09:38 ET | 3987 | 0.6317 |
| 09:39 ET | 900 | 0.624 |
| 09:41 ET | 1200 | 0.6302 |
| 09:43 ET | 400 | 0.6287 |
| 09:45 ET | 400 | 0.6286 |
| 09:48 ET | 58578 | 0.6265 |
| 09:50 ET | 3100 | 0.62 |
| 09:52 ET | 4600 | 0.62 |
| 09:54 ET | 4432 | 0.6205 |
| 09:56 ET | 3182 | 0.6253 |
| 09:57 ET | 3948 | 0.6221 |
| 09:59 ET | 52064 | 0.6201 |
| 10:01 ET | 11700 | 0.62415 |
| 10:03 ET | 400 | 0.6204 |
| 10:06 ET | 6824 | 0.62485 |
| 10:08 ET | 6600 | 0.628 |
| 10:10 ET | 5850 | 0.6306 |
| 10:14 ET | 900 | 0.63445 |
| 10:15 ET | 1000 | 0.6345 |
| 10:17 ET | 100 | 0.6346 |
| 10:19 ET | 40700 | 0.6301 |
| 10:21 ET | 5799 | 0.6307 |
| 10:24 ET | 2396 | 0.6293 |
| 10:26 ET | 2309 | 0.6268 |
| 10:28 ET | 500 | 0.6272 |
| 10:30 ET | 300 | 0.6272 |
| 10:32 ET | 12740 | 0.627 |
| 10:33 ET | 400 | 0.6272 |
| 10:35 ET | 2100 | 0.6308 |
| 10:37 ET | 3475 | 0.6271 |
| 10:39 ET | 1500 | 0.6273 |
| 10:42 ET | 6276 | 0.627 |
| 10:44 ET | 11600 | 0.62911 |
| 10:46 ET | 4350 | 0.6345 |
| 10:48 ET | 1300 | 0.6329 |
| 10:50 ET | 2637 | 0.6268 |
| 10:51 ET | 4966 | 0.6224 |
| 10:53 ET | 14851 | 0.6226 |
| 10:55 ET | 900 | 0.6226 |
| 10:57 ET | 53049 | 0.6178 |
| 11:00 ET | 25638 | 0.62 |
| 11:02 ET | 21312 | 0.62 |
| 11:04 ET | 9466 | 0.62 |
| 11:06 ET | 2858 | 0.62 |
| 11:08 ET | 50860 | 0.62 |
| 11:09 ET | 19625 | 0.620201 |
| 11:13 ET | 24685 | 0.6234 |
| 11:15 ET | 600 | 0.6226 |
| 11:20 ET | 1879 | 0.6254 |
| 11:22 ET | 100 | 0.6252 |
| 11:24 ET | 500 | 0.6251 |
| 11:26 ET | 300 | 0.6252 |
| 11:27 ET | 55664 | 0.63 |
| 11:31 ET | 780 | 0.6299 |
| 11:33 ET | 500 | 0.6299 |
| 11:36 ET | 15580 | 0.6294 |
| 11:38 ET | 1125 | 0.6267 |
| 11:40 ET | 1344 | 0.6272 |
| 11:42 ET | 700 | 0.6267 |
| 11:44 ET | 1700 | 0.6281 |
| 11:45 ET | 7800 | 0.6291 |
| 11:47 ET | 10072 | 0.6266 |
| 11:49 ET | 1500 | 0.6266 |
| 11:51 ET | 900 | 0.6277 |
| 11:54 ET | 2390 | 0.6222 |
| 11:56 ET | 900 | 0.6218 |
| 11:58 ET | 8400 | 0.62 |
| 12:00 ET | 400 | 0.62 |
| 12:02 ET | 1000 | 0.62 |
| 12:03 ET | 800 | 0.62225 |
| 12:05 ET | 1200 | 0.6237 |
| 12:07 ET | 14333 | 0.634 |
| 12:09 ET | 900 | 0.634 |
| 12:12 ET | 3602 | 0.6338 |
| 12:14 ET | 1420 | 0.6327 |
| 12:18 ET | 4300 | 0.63305 |
| 12:20 ET | 1900 | 0.6317 |
| 12:21 ET | 300 | 0.6267 |
| 12:23 ET | 2600 | 0.63262 |
| 12:25 ET | 9600 | 0.6308 |
| 12:27 ET | 2400 | 0.6323 |
| 12:30 ET | 2954 | 0.6314 |
| 12:32 ET | 500 | 0.6322 |
| 12:34 ET | 700 | 0.6322 |
| 12:36 ET | 3205 | 0.6325 |
| 12:38 ET | 20341 | 0.6327 |
| 12:39 ET | 22550 | 0.6324 |
| 12:41 ET | 500 | 0.6323 |
| 12:43 ET | 900 | 0.6323 |
| 12:45 ET | 1000 | 0.6318 |
| 12:48 ET | 2298 | 0.6297 |
| 12:50 ET | 3200 | 0.6293 |
| 12:52 ET | 900 | 0.6277 |
| 12:54 ET | 690 | 0.6241 |
| 12:56 ET | 700 | 0.62 |
| 12:57 ET | 200 | 0.62 |
| 12:59 ET | 691 | 0.6201 |
| 01:01 ET | 500 | 0.6244 |
| 01:03 ET | 650 | 0.6203 |
| 01:06 ET | 600 | 0.6244 |
| 01:08 ET | 1100 | 0.6245 |
| 01:10 ET | 1000 | 0.6245 |
| 01:12 ET | 4181 | 0.6266 |
| 01:14 ET | 661 | 0.6256 |
| 01:15 ET | 14156 | 0.6264 |
| 01:17 ET | 68040 | 0.6335 |
| 01:19 ET | 20228 | 0.633 |
| 01:21 ET | 2300 | 0.6331 |
| 01:24 ET | 700 | 0.6332 |
| 01:26 ET | 20900 | 0.6333 |
| 01:28 ET | 300 | 0.6332 |
| 01:30 ET | 9856 | 0.63 |
| 01:32 ET | 1500 | 0.6294 |
| 01:33 ET | 14300 | 0.6385 |
| 01:37 ET | 10879 | 0.6403 |
| 01:39 ET | 44282 | 0.6458 |
| 01:42 ET | 3302 | 0.6455 |
| 01:44 ET | 4414 | 0.6423 |
| 01:46 ET | 200 | 0.6391 |
| 01:48 ET | 3138 | 0.6361 |
| 01:50 ET | 3200 | 0.6398 |
| 01:51 ET | 8900 | 0.64 |
| 01:53 ET | 5900 | 0.64 |
| 01:55 ET | 4446 | 0.6362 |
| 01:57 ET | 500 | 0.6362 |
| 02:00 ET | 600 | 0.6363 |
| 02:02 ET | 400 | 0.6362 |
| 02:04 ET | 800 | 0.6362 |
| 02:06 ET | 500 | 0.63785 |
| 02:08 ET | 600 | 0.6362 |
| 02:09 ET | 600 | 0.6362 |
| 02:11 ET | 3200 | 0.6396 |
| 02:13 ET | 4600 | 0.6367 |
| 02:15 ET | 5156 | 0.6378 |
| 02:18 ET | 4237 | 0.6375 |
| 02:20 ET | 15916 | 0.6378 |
| 02:22 ET | 23419 | 0.63865 |
| 02:24 ET | 5397 | 0.63925 |
| 02:26 ET | 22926 | 0.6407 |
| 02:27 ET | 19559 | 0.6467 |
| 02:29 ET | 3800 | 0.6443 |
| 02:31 ET | 2100 | 0.6418 |
| 02:33 ET | 9076 | 0.6441 |
| 02:36 ET | 2500 | 0.6445 |
| 02:38 ET | 2300 | 0.64465 |
| 02:40 ET | 1400 | 0.6448 |
| 02:42 ET | 4900 | 0.6439 |
| 02:44 ET | 1454 | 0.6351 |
| 02:45 ET | 400 | 0.6351 |
| 02:47 ET | 4911 | 0.6351 |
| 02:49 ET | 857 | 0.6351 |
| 02:51 ET | 600 | 0.6393 |
| 02:54 ET | 500 | 0.6393 |
| 02:56 ET | 2037 | 0.6393 |
| 02:58 ET | 3820 | 0.6393 |
| 03:00 ET | 1100 | 0.6353 |
| 03:02 ET | 500 | 0.6351 |
| 03:03 ET | 4424 | 0.63905 |
| 03:05 ET | 4713 | 0.6352 |
| 03:07 ET | 15487 | 0.6391 |
| 03:09 ET | 12230 | 0.6391 |
| 03:12 ET | 3382 | 0.6391 |
| 03:14 ET | 3318 | 0.6354 |
| 03:16 ET | 50243 | 0.636 |
| 03:18 ET | 6388 | 0.64185 |
| 03:20 ET | 1598 | 0.64185 |
| 03:21 ET | 9130 | 0.6377 |
| 03:23 ET | 3459 | 0.63805 |
| 03:25 ET | 12521 | 0.6394 |
| 03:27 ET | 2664 | 0.6402 |
| 03:30 ET | 4100 | 0.6412 |
| 03:32 ET | 1100 | 0.6406 |
| 03:34 ET | 2124 | 0.6421 |
| 03:36 ET | 3445 | 0.642 |
| 03:38 ET | 16575 | 0.64245 |
| 03:39 ET | 6125 | 0.6424 |
| 03:41 ET | 7633 | 0.6425 |
| 03:43 ET | 4600 | 0.6424 |
| 03:45 ET | 3385 | 0.6423 |
| 03:48 ET | 7360 | 0.6412 |
| 03:50 ET | 19322 | 0.641 |
| 03:52 ET | 17664 | 0.6411 |
| 03:54 ET | 33384 | 0.641 |
| 03:56 ET | 51988 | 0.6411 |
| 03:57 ET | 22120 | 0.6403 |
| 03:59 ET | 58784 | 0.6322 |
May 10, 2023
--Jefferies Upgrades Nektar Therapeutics to Hold From Underperform, Adjusts Price Target to $1 From $1.50, from 9:44AM ET on Wednesday May 10, 2023 by MT Newswires
9:44AM ET on Wednesday May 10, 2023 by MT Newswires
May 9, 2023
BRIEF-Nektar Therapeutics Reports First Quarter 2023 Financial Results, from 6:13PM ET on Tuesday May 09, 2023 by Thomson Reuters
6:13PM ET on Tuesday May 09, 2023 by Thomson Reuters-- Earnings Flash (NKTR) NEKTAR THERAPEUTICS Posts Q1 Revenue $21.6M, from 4:22PM ET on Tuesday May 09, 2023 by MT Newswires
4:22PM ET on Tuesday May 09, 2023 by MT NewswiresNektar Therapeutics Reports First Quarter 2023 Financial Results, from 4:15PM ET on Tuesday May 09, 2023 by PR Newswire
4:15PM ET on Tuesday May 09, 2023 by PR Newswire
Apr 27, 2023
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Nektar Therapeutics | 119.6M | -0.3x | --- |
Societal CDMO Inc | 68.6M | -2.5x | --- |
OptiNose Inc | 135.5M | -1.6x | --- |
Esperion Therapeutics Inc | 138.3M | -0.4x | --- |
Kali Inc | 1.0K | 0.0x | --- |
Aytu Biopharma Inc | 6.4M | 0.0x | --- |
Company Information
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company. The Company is focused on discovering and developing medicines in the field of immunotherapy. The Company has a research and development pipeline of investigational medicines in oncology and immunology. In oncology, it is focused on developing medicines based on targeting biological pathways that stimulate and sustain the body’s immune response to fight cancer. Its pipeline NKTR-255 is an investigational biologic that is designed to target the interleukin-15 (IL-15) pathway in order to activate the body’s innate and adaptive immunity. Its Rezpegaldesleukin (REZPEG) pipeline is an investigational, potential first-in-class T regulatory cell stimulator that addresses this underlying immune system imbalance in people with many autoimmune and inflammatory conditions. REZPEG is being developed as a self-administered injection for a number of autoimmune and inflammatory diseases.
Contact Information
- Headquarters
- 455 Mission Bay Blvd SSAN FRANCISCO, CA, United States 94158-2158
- Phone
- 415-482-5300
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Robert Chess
- President, Chief Executive Officer, Director
- Howard Robin
- Interim Chief Financial Officer
- Sandra Gardiner
- Senior Vice President - Technical Operations
- Kevin Brodbeck
- Senior Vice President, Chief Legal Officer
- Mark Wilson
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $119.6M |
|---|---|
Revenue (TTM) | $88.8M |
Shares Outstanding | 189.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.09 |
EPS | $-2.21 |
Book Value | $1.94 |
P/E Ratio | -0.3x |
Price/Sales (TTM) | 1.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -443.91% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
